egtazic acid has been researched along with Neurofibromatosis 1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeVries, GH; Farrer, JR; Farrer, RG | 1 |
1 other study(ies) available for egtazic acid and Neurofibromatosis 1
| Article | Year |
|---|---|
Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.
Topics: Angiogenesis Inducing Agents; Becaplermin; Calcium; Calmodulin; Cell Line; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Humans; Neurofibromatosis 1; Neurofibromin 1; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Receptors, Platelet-Derived Growth Factor; Schwann Cells; Sulfonamides | 2013 |